United Kingdom · Question · Written question
UIN 97701
Respiratory Syncytial Virus: Children
Original
Introduced
28 November 2022
Last action
8 December 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
8 December 2022
Summary
To ask the Secretary of State for Health and Social Care, if he will publish the recommendations of NHS England’s Palivizumab National Expert Group on the eligibility of a sub-group of children with spinal muscular atrophy to receive a palivizumab vaccina
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 November 2022
Written question
To ask the Secretary of State for Health and Social Care, if he will publish the recommendations of NHS England’s Palivizumab National Expert Group on the eligibility of a sub-group of children with spinal muscular atrophy to receive a palivizumab vaccina
Source: Commons
8 December 2022
Answer
The Palivizumab National Expert Group considered the eligibility of a specific group of children with spinal muscular atrophy (SMA) to receive a palivizumab vaccination. While the Expert Group was supportive in principle of adding SMA type 1 patients to t...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-11-28/97701
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1545959
- uk · wq-1545959 · source updated 8 December 2022